Valuation: Lonza Group AG

Market Cap 39.96B 49.47B 42.8B 36.66B 68.96B 4,709B 70.05B 469B 184B 2,360B 186B 182B 7,802B P/E 2026 *
33.6x
P/E 2027 * 28x
Enterprise Value 42.78B 52.96B 45.81B 39.24B 73.81B 5,040B 74.98B 502B 197B 2,526B 199B 195B 8,352B EV / Sales 2026 *
6x
EV / Sales 2027 * 5.37x
Free-Float
99.36%
Yield 2026 *
0.95%
Yield 2027 * 1.1%
1 day+0.52%
1 week+1.78%
Current month+1.78%
1 month-1.79%
3 months+18.47%
6 months+10.93%
Current year+6.40%
1 week 552.8
Extreme 552.8
579.6
1 month 527.4
Extreme 527.4
588.8
Current year 454.6
Extreme 454.6
591
1 year 454.6
Extreme 454.6
591
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
785.4
10 years 156.2
Extreme 156.2
785.4
Manager TitleAgeSince
Chief Executive Officer 54 2024-06-30
Director of Finance/CFO 54 2021-11-30
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Director/Board Member 67 2016-04-25
Director/Board Member 66 2018-05-03
Director/Board Member 60 2022-05-04
Date Insider Type Main position Quantity % Market Cap.
10/27/25 Sell 60 0.0001%
7/28/25 Sell 90 0.0001%
5/29/25 Buy 100 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.56%+1.78%+5.07%+17.01% 49.47B
+3.71%+9.40%+486.14%+592.61% 43.97B
+5.60%+10.21%+20.85%+73.63% 39.6B
+2.70%+1.57%+32.71%+9.15% 39.29B
+2.21%+6.75%+20.20%+47.53% 32.43B
+2.23%+4.71% - - 16.84B
+0.97%+2.35%+35.99%+122.50% 16.49B
-0.11%+3.04%+5.34%+18.39% 14.01B
+0.75%+15.04%+79.84%+23.95% 12.77B
+2.07%+0.58%+3.83%-35.14% 12.69B
Average +2.08%+5.74%+76.66%+96.63% 27.76B
Weighted average by Cap. +2.44%+5.85%+100.22%+129.84%

Financials

2026 *2027 *
Net sales 7.13B 8.83B 7.64B 6.54B 12.3B 840B 12.5B 83.66B 32.83B 421B 33.15B 32.42B 1,392B 7.96B 9.85B 8.52B 7.3B 13.73B 937B 13.95B 93.34B 36.64B 470B 36.99B 36.18B 1,553B
Net income 1.21B 1.49B 1.29B 1.11B 2.08B 142B 2.12B 14.17B 5.56B 71.3B 5.61B 5.49B 236B 1.42B 1.75B 1.52B 1.3B 2.44B 167B 2.48B 16.62B 6.52B 83.67B 6.59B 6.44B 277B
Net Debt 2.81B 3.48B 3.01B 2.58B 4.85B 332B 4.93B 33.01B 12.96B 166B 13.08B 12.79B 549B 2.72B 3.37B 2.92B 2.5B 4.7B 321B 4.77B 31.94B 12.54B 161B 12.66B 12.38B 532B
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the contract development and manufacturing of pharmaceutical and biotechnology products. Net sales break down by family of products and services as follows: - biologics and bio-pharmaceuticals (55.9%): microbiological fermentation products, mammalian cell-based bio-pharmaceuticals, monoclonal antibodies, therapeutic proteins, etc.; - synthesis products (24.7%): chemopharmaceutical products, bioconjugates, small molecules, active pharmaceutical ingredients, complex intermediates, etc.; - specialised therapeutic products (15.8%): cell and gene therapies, synthetic therapeutic nucleic acids, oligonucleotides, microbial biological products, etc.; - others (3.6%).
Employees
20,141
Date Price Change Volume
26-08-10 CHF 574.20 +0.35% 9,683
26-08-07 CHF 572.20 +0.99% 110,508
26-08-06 CHF 566.60 +0.93% 98,994
26-08-05 CHF 561.40 +0.90% 95,131
26-08-04 CHF 556.40 -0.68% 126,978
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
572.20CHF
Average target price
681.13CHF
Spread / Average Target
+19.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LONN Stock